CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjögren's Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05985915
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-29T15:20:05.606601+00:00
Published At: 2026-04-29T00:00:00+00:00
Record Updated At: 2026-04-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Sjogrens Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-29"
protocolSection.identificationModule.nctId: "NCT05985915"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sj\u00f6gren\u0027s Syndrome"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.